Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. | Pharmaceuticals (Basel) | 2021 | 34207383 | PubTator, text mining | PubMed |
| lncRNA LINC01296 Promotes Oral Squamous Cell Carcinoma Development by Binding with SRSF1. | Biomed Res Int | 2021 | 34195277 | PubTator, text mining | PubMed |
| A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. | Clin Epigenetics | 2021 | 34193246 | PubTator, text mining | PubMed |
| The plasma peptides of Alzheimer's disease. | Clin Proteomics | 2021 | 34182925 | PubTator, text mining | PubMed |
| Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. | World J Gastroenterol | 2021 | 34168400 | PubTator, text mining | PubMed |
| Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors. | Cancer Chemother Pharmacol | 2021 | 34164713 | PubTator, text mining | PubMed |
| Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1. | Sci Rep | 2021 | 34162944 | PubTator, text mining | PubMed |
| Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. | Front Cell Dev Biol | 2021 | 34150764 | PubTator, text mining | PubMed |
| Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis. | Osteoporos Int | 2021 | 34142171 | PubTator, text mining | PubMed |
| In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients. | Infect Dis Ther | 2021 | 34137000 | PubTator, text mining | PubMed |
| The roles of integrins in cancer. | Fac Rev | 2021 | 34131655 | PubTator, text mining | PubMed |
| 4D analysis of malaria parasite invasion offers insights into erythrocyte membrane remodeling and parasitophorous vacuole formation. | Nat Commun | 2021 | 34131147 | PubTator, text mining | PubMed |
| Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-?B pathway in the pathogenesis of cancer. | EXCLI J | 2021 | 34121970 | PubTator, text mining | PubMed |
| Characterisation of patients with supine nighttime reflux: observations made with prolonged wireless oesophageal pH monitoring. | Aliment Pharmacol Ther | 2021 | 34114652 | PubTator, text mining | PubMed |
| Roles for growth factors and mutations in metastatic dissemination. | Biochem Soc Trans | 2021 | 34100888 | PubTator, text mining | PubMed |
| The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR. | Exp Ther Med | 2021 | 34093754 | PubTator, text mining | PubMed |
| Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. | Front Immunol | 2021 | 34093595 | PubTator, text mining | PubMed |
| RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets. | World J Gastroenterol | 2021 | 34092972 | PubTator, text mining | PubMed |
| CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms. | Nucleic Acids Res | 2021 | 34086943 | PubTator, text mining | PubMed |
| In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1. | Int J Mol Sci | 2021 | 34072728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=25